## Abstract In this issue of the __European Journal of Immunology (EJI),__ Stewart __et al.__ report about a population of γδ‐T cells expressing an extensive repertoire of NK cell receptors, and the presence of non‐rearranged germline TCRδ transcripts in conventional NK cells. These findings and ot
Back to the future: Moving beyond “mesenchymal stem cells”
✍ Scribed by Paolo Bianco
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 210 KB
- Volume
- 112
- Category
- Article
- ISSN
- 0730-2312
No coin nor oath required. For personal study only.
✦ Synopsis
The last decade was dominated by dissemination of the notion that postnatal “mesenchymal stem cells,” found primarily in bone marrow but also in other tissues, can generate multiple skeletal and nonskeletal tissues, and thus can be exploited to regenerate a broad range of tissues and organs. The concept of “mesenchymal stem cells” and its applicative implications represent a significant departure from the solidly proven notion that skeletal stem cells are found in the bone marrow (and not in other tissues). Recent data that sharpen our understanding of the identity, nature, origin, and in vivo function of the archetypal “mesenchymal stem cells” (bone marrow skeletal stem cells) point to their microvascular location, mural cell identity, and function as organizers and regulators of the hematopoietic microenvironment/niche. These advances bring back the original concept from which the notion of “mesenchymal stem cells” evolved, and clarify a great deal of experimental data that accumulated in the past decade. As a novel paradigm emerges that accounts for many facets of the biology of skeletal stem cells, a novel paradigm independently emerges for their applicative/translational use. The two paradigms meet each other back in the future. J. Cell. Biochem. 112: 1713–1721, 2011. © 2011 Wiley-Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract Stem cell‐based therapies hold much promise for the rejuvenation of aged or damaged tissues; however, before such cells can be used therapeutically, they must first be accurately identified. In this issue of the __European Journal of Immunology__ it is reported that MTS24, a marker prev
## Abstract Human bone marrow derived‐mesenchymal (skeletal) stem (MSC) cells are a group of non‐hematopoietic stem cells residing in the perivascular niches in bone marrow. These cells have the capacity to differentiate mainly into mesoderm‐type cells such as osteoblasts, chondrocytes and adipocyt
## Abstract Pluripotent stem cells, embryonic stem (ES) cells and induced pluripotent stem (iPS) cells, both hold great promise for the understanding and treatment of disease. They can be used for drug testing, as in vitro models for human disease progression, and for transplantation therapies. Res
Ductal tips approximately 300 pm in length from adult rat dorsal (DP), lateral type 1 (Ll), and lateral type 2 (L2) prostates were combined with mesenchyme from the embryonic urogenital sinus (UGM), neonatal seminal vesicle (SVM), or neonatal bulbourethral gland (BUGM) and grafted underneath the ren
## Abstract Mesenchymal stem cells (MSCs) can differentiate into multiple nonhematopoietic cell lineages, including osteoblasts, chondrocytes, and ligament cells. The purpose of this study is to identify the difference between MSCs and anterior cruciate ligament (ACL) cells for the application of d